Substituted imidazolidin-2-ones deduced as potential inhibitors of IleRS by docking simulations were synthesized from an aziridine-2-carboxaldehyde. Reductive amination of an aziridine-2-carboxaldehyde with dipeptides for the substituents at N1 and followed by aziridine-ring expansion with triphosgene afforded 4-chloromethylimidazolidin-2-ones whose chloride were further manipulated towards phenylurea, pyrimidin-2-yl-urea or benzenesulfonamide at C4.
Introduction
Aminoacyl-tRNA synthetases (aaRS), an enzyme responsible for the protein biosynthesis for all organisms, are interesting antibacterial drug target. 1 One commercial antibiotic named mupirocin is a natural product isolated from Pseudomonas fluorescens which inhibits bacterial aaRS ( Figure 1) . 2 More specifically it is a bifunctional inhibitor of IleRS with respect to both isoleucine and ATP binding. 3 Whole chemical structure of mupirocin is quite different from the isoleucyl-adenylate reaction intermediate (Ile-AMP) except the isoleucyl moiety in the tail part. However, both mupirocin and the reactive intermediate bind in very similar regions within the enzyme. 4 Many compounds for the potential inhibitor were devised on the basis of the structural knowledge binding the enzyme to the inhibitors.
In our early publication 5 we performed docking simulations with 48 different compounds and some of them showed good binding capabilities for IleRS (S. aureus). They have imidazolidin-2-one as a common core heterocycle with a substituent of dipeptide at N1 and phenylurea (1), pyrimidin-2-yl-urea (2) or benzenesulfonamide (3) at C4. Dipeptide consists with substituents in R1 and R2 originated from either leucine (L) isoleucine (I) (Figure 2 ). All of these were synthesized and evaluated as IleRS (E.coli and S.aureus) inhibitors.
Results and Discussion
Synthesis starts from reductive amination of an aziridine-2-carboxaldehyde (4) 6 and amine part of dipeptide methylester (5) to yield 6. The following aziridine-ring expansion afforded 4-chloromethylimidazolidin-2-one (7) with triphosgene in the presence of NaH. 7 Removal of phenylethyl group 8 and the change of chlorine to amine via azide gave common synthetic intermediate 9, which was further reacted with phenylisocyanate 9 , pyrimidin-2-yl-carbamate 10 and benzene sulfonyl chloride to afford 10, 11 and 12 respectively. Target molecules bearing imidazolidin-2-one as a core heterocycle with a substituent of dipeptide at N1 and with one of three groups among phenylurea (1), pyrimidin-2-yl-urea (2) or benzenesulfonamide (3) at C4. were attained from hydrolysis of the corresponding methyl † This paper is dedicated to Professor Sunggak Kim on the occasion of his honorable retirement. esters 10, 11 and 12 respectively. All of the synthesized compounds were evaluated as IleRS (E.coli and S.aureus) inhibitors with two different concentration as 200 and 20 µM respectively. 11 Unfortunately, none of the synthesized compounds showed quite significant inhibitory activity against both IleRS. At this moment we were not able to explain the big discrepancy between the molecular docking study and real inhibitory activity.
In conclusion, we synthesized compounds bearing imidazolidin-2-one as a core heterocycle with a substituent of dipeptide at N1 and with one of three groups among phenylurea (1), pyrimidin-2-yl-urea (2) or benzenesulfonamide (3) at C4.
Experimental
Chiral aziridines are available from Aldrich. All commercially available compounds were used as received unless stated otherwise. All reactions were carried out under an atmosphere of nitrogen in oven-dried glassware with magnetic stirring. Reactions were monitored by thin layer chromatography (TLC) with 0.25 mm E. Merck pre-coated silica gel plates (60 F254). Visualization was accomplished with either UV light, or by immersion in solutions of ninhydrin, p-anisaldehyde, or phosphomolybdic acid (PMA) followed by heating on a hot plate for about 10 sec. Purification of the reaction products was carried out by flash chromatography using Kieselgel 60 Art 9385 (230 -400 mesh). 
Preparation of amino acid dimers (LL, LI, II and IL).
To the solution of Boc-leucine (3 g, 13 mmol) in 20 mL of EtOAc under nitrogen at room temperature was added 4-methylmorpholine (1.5, 13.7 mmol), HOBt (0.18 g, 1.3 mmol). To the above mixture were added leucine methyl ester (2.36 g, 13 mmol), DCC (3.2 g, 14.6 mmol) in 3 mL EtOAc. The mixture was stirred for 2 hours at room temperature. The resulting urea was removed by filtration. The mixture was treated with water, and the aqueous layer was separated and extracted with EtOAc. The combined organic extracts were washed with 5% K2CO3, 5% KHSO4, and brine. The organic layer was dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Residue was recystallization from pet ether to provide 92% of N-Boc
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Bull. Korean Chem. Soc. 2010, Vol. 31, No. 3 613 protected leucine-leucine (LL) dimer. After mixture was treated with 4 N HCl in dioxane, Boc deprotected leucine-leucine (LL) dimer methyl ester was obtained which is ready to be coupled with aldehyde. All other three dimers including leucine-isoeucine (LI), isoleucine-isoeucine (II) and isoleucine-leucine (IL) methyl ester were prepared in the same manner starting from the corresponding amino acids.
Preparation of 6. To the solution of deprotected leucine-leucine (LL) dimer methyl ester (2.6 g, 10.2 mmol) in 70 mL of CH2Cl2 under nitrogen at room temperature were added aziridine aldehyde (1.78 g, 10.2 mmol) and anhydrous MgSO4 (10 g). The solution was stirred for 5 hours and the mixture was filtered and concentrated in vacuo. After the crude product was dissolved in 25 mL of MeOH at room temperature was added NaCNBH4 (0.96 g, 15.3 mmol). The mixture was stirred for overnight and then quenched with water. The organic layer was separated and the aqueous layer was extracted with CH2Cl2. The combined organic extracts were washed with brine, dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel flash chromatography (EtOAc/n-Hexane, 33:66) gave 1.93 g (59%) of the product (6LL) as colorless oil. Preparation of 8. To the solution of compound 7LL (1.86 g, 3.87 mmol) in 50 mL of hexane at room temperature, was added MsOH (1.25 mL, 19.4 mmol) and anisole (1.05 mL, 9.67 mmol). The mixture was refluxed for 4 hours, cooled and then quenched with 1 mL of saturated NaHCO3 solution. The organic layer was separated and the aqueous layer was extracted with CH2Cl2. The combined organic extracts were dried over anhydrous MgSO 4 , filtered, and concentrated in vacuo. Purification by silica gel flash chromatography (CH2Cl2/MeOH, 10:1) gave debenzylated product 1.0 g (69%). To the solution of debenzylated product (1.0 g, 2.66 mmol) in 10 mL of DMF was added NaN3 (0.34 g, 5.3 mmol). The mixture was stirred for overnight at 80 o C. The mixture was cooled, organic layer was separated and the aqueous layer was extracted with EtOAc. The combined organic extracts were washed with brine (10 mL × 3) dried over anhydrous MgSO4, filtered, and concentrated in vacuo. Purification by silica gel flash chromatography (CH 2 Cl 2 /MeOH, 10:1) gave 0.4 g (40%) of the product 8LL. 38 (m, 2H), 3.21 (m, 1H), 1.68-1.56 (m, 6H) , 0.99-0.91 (m, 12H). All other three, 8LI, 8II and 8IL, were prepared in the same manner as for 8LL.
Preparation of 9. To the solution of compound 8LL (300 mg, 0.78 mmol) in 20 mL of MeOH was added Pd/C (0.1 g) and the resulting solution was stirred for overnight under atmospheric pressure of H2 at room temperature. The solution was filtered and concentrated in vacuo to yield crude product 9LL. All other three, 9LI, 9II and 9IL, were prepared in the same manner as for 9LL. Preparation of 10. To the solution of compound 9LL (25 mg, 0.07 mmol) in 3 mL of THF was added phenyl isocyanate (7.6 µL, 0.07 mmol). The mixture was stirred for 3 hours at room temperature. The solution was concentrated in vacuo to yield crude product. Purification by silica gel flash chromatography (EtOAc/n-Hexane, 2:1) gave 20 mg of the product 10LL; To the solution of compound 11LL (14 mg, 0.04 mmol) in 2 mL of THF was added benzene sulfonyl chloride (6 µL, 0.05 mmol) and TEA (3 µL). The mixture was refluxed for 1 hour. The solution was concentrated in vacuo to yield crude product. Purification by silica gel flash chromatography (CH2Cl2/MeOH, 10:1) gave 9 mg of the product 12LL; 
